Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.36 |
| ▸ | ALOX5AP | P20292 | 4/20 | 0.34 |
| ▸ | FEN1 | P39748 | 4/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 3/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11939969 | 0.91 | ALOX5AP (0.34) | FFAR4ALOX5APFEN1L3MBTL1MEN1 | |
| SCHEMBL15381522 | 0.87 | HPGD (0.42) | FFAR4ALOX5APFEN1DGAT1HPGD | |
| SCHEMBL11939843 | 0.86 | KMT2A (0.41) | ALOX5APFEN1L3MBTL1MEN1RAB9A | |
| SCHEMBL11938883 | 0.86 | KMT2A (0.41) | ALOX5APFEN1L3MBTL1MEN1RAB9A | |
| SCHEMBL12223561 | 0.84 | KMT2A (0.41) | L3MBTL1MEN1RAB9AKMT2AESR1 | |
| SCHEMBL12223512 | 0.83 | L3MBTL1 (0.39) | L3MBTL1MEN1RAB9AKMT2AESR1 | |
| SCHEMBL11933236 | 0.83 | HPGD (0.39) | FFAR4ALOX5APFEN1DGAT1HPGD | |
| SCHEMBL15381724 | 0.82 | HPGD (0.38) | FFAR4ALOX5APFEN1MEN1KMT2A | |
| SCHEMBL12823303 | 0.82 | HPGD (0.40) | ALOX5APFEN1L3MBTL1RAB9AKMT2A | |
| SCHEMBL11939154 | 0.81 | ALOX5AP (0.40) | FFAR4ALOX5APFEN1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120168677-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120168677-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | CXCR1, OCIAD1, LEO1 | FFAR4 1038/4885ALOX5AP 903/4885FEN1 1475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.